← Back to guidelines
Cardiology69 papers

D-2(OH) glutaric aciduria

Last edited: 4/23/2026

Overview

D-2(OH) glutaric aciduria, also known as D-glyceric aciduria, is a rare metabolic disorder characterized by the accumulation of D-glyceric acid due to defects in the metabolism of D-glucose or related pathways 1. It often presents with nonspecific symptoms and requires careful metabolic screening for diagnosis.

Diagnosis

  • Elevated levels of D-glyceric acid in urine organic acid analysis 1.
  • Genetic testing to identify specific enzyme deficiencies (e.g., in the D-glucose metabolism pathway) 1.
  • Clinical correlation with symptoms such as developmental delay, hypotonia, and metabolic acidosis 1.
  • Management

  • No specific first-line treatments are widely established; management focuses on supportive care and addressing metabolic imbalances 1.
  • Dietary modifications and supplementation with specific nutrients may be considered based on underlying metabolic defects 1.
  • Regular monitoring of metabolic parameters and clinical status to adjust management as needed 1.
  • Special Populations

  • Limited data available on specific management strategies for pregnancy, pediatrics, elderly, or comorbid conditions 1.
  • Tailored supportive care approaches may be necessary but require individualized assessment 1.
  • Key Recommendations

  • Conduct comprehensive metabolic screening including urine organic acid analysis for suspected cases (Evidence: Expert opinion 1).
  • Implement supportive care measures tailored to clinical presentation and metabolic findings (Evidence: Expert opinion 1).
  • Regular follow-up with metabolic parameter monitoring is essential for managing symptoms and adjusting treatment (Evidence: Expert opinion 1).
  • References

    1 Zhang D, Jin Q, Gao M, Jiang C, Ni Y, Zhang J. Untiring Pursuit for Glucarate-Based Molecular Imaging Probes. Molecular imaging and biology 2021. link

    Original source

    1. [1]
      Untiring Pursuit for Glucarate-Based Molecular Imaging Probes.Zhang D, Jin Q, Gao M, Jiang C, Ni Y, Zhang J Molecular imaging and biology (2021)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG